Dinesh Kundu | CEO
East Ocyon Bio Pvt. Ltd.

Dr. Dinesh Kundu is the CEO & Co-founder of East Ocyon Bio, India’s first allogeneic cell therapy company developing CAR-NK and CAR-Gamma Delta T cell therapies for solid tumors, autoimmune diseases, and rare disorders. A physician by training and former Army doctor, he brings over 15 years of experience in biologics and immunotherapy from leadership roles at Intas, Wockhardt, and Biosimilar Solutions US. At East Ocyon, he is advancing affordable, off-the-shelf immunotherapies for underserved markets, and actively shaping India’s CGT regulatory landscape. Dr. Kundu is a vocal advocate for global access and South-South innovation in cell and gene therapies.